» Authors » Marta Jeison

Marta Jeison

Explore the profile of Marta Jeison including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 297
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Jeison M, Yaniv I, Ash S
Future Oncol . 2011 Sep; 7(9):1087-99. PMID: 21919696
Neuroblastoma is the most common extracranial tumor of childhood. The clinical behavior is variable, ranging from spontaneous regression to fatal progression despite aggressive therapy. The most highly statistically significant and...
12.
De Weer A, Van der Meulen J, Rondou P, Taghon T, Konrad T, De Preter K, et al.
Br J Haematol . 2011 May; 154(3):337-48. PMID: 21569010
Chromosomal rearrangements involving the MECOM (MDS1 and EVI1 complex) locus are recurrent genetic events in myeloid leukaemia and are associated with poor prognosis. In this study, we assessed the role...
13.
Ambros I, Brunner B, Aigner G, Bedwell C, Beiske K, Benard J, et al.
Clin Cancer Res . 2011 Feb; 17(4):792-804. PMID: 21325297
Purpose: Precise and comprehensive analysis of neuroblastoma genetics is essential for accurate risk evaluation and only pangenomic/multilocus approaches fulfill the present-day requirements. We present the establishment and validation of the...
14.
Jeison M, Ash S, Halevy-Berko G, Mardoukh J, Luria D, Avigad S, et al.
Am J Pathol . 2010 Apr; 176(6):2616-25. PMID: 20395439
Although the role of MYCN amplification in neuroblastoma is well established, the biological and clinical characteristics of the 2p gain region harboring the MYCN gene remain unclear. The aim of...
15.
Feinberg-Gorenshtein G, Avigad S, Jeison M, Halevy-Berco G, Mardoukh J, Luria D, et al.
Genes Chromosomes Cancer . 2009 Apr; 48(7):539-43. PMID: 19373781
Neuroblastoma (NB) is the most common extracranial solid tumor in children below the age of 5 years. miR-34a, located in chromosome band 1p36, has been recently implicated as a tumor...
16.
Avigad S, Feinberg-Gorenshtein G, Luria D, Jeison M, Stein J, Grunshpan A, et al.
J Pediatr Hematol Oncol . 2009 Jan; 31(1):22-6. PMID: 19125082
Purpose: We investigated whether detection of minimal residual disease (MRD) in peripheral blood stem cells (PBSC) by using tyrosine hydroxylase (TH) expression could predict outcome of patients with advanced neuroblastoma....
17.
Avigad S, Naumov I, Ohali A, Jeison M, Berco G, Mardoukh J, et al.
Clin Cancer Res . 2007 Oct; 13(19):5777-83. PMID: 17908968
Purpose: Despite advances in therapy, >50% of patients with Ewing sarcoma will relapse. The current prognostic factors are not optimal for risk prediction. Studies have shown that telomere length could...
18.
Stark B, Jeison M, Gabay L, Mardoukh J, Luria D, Bar-Am I, et al.
Br J Haematol . 2004 Jul; 126(3):320-37. PMID: 15257704
The incidence of cytogenetic abnormalities in childhood de novo acute myeloid leukaemia (AML) and its prognostic significance was assessed in an Israeli paediatric referral centre. Cytogenetic analysis was successful in...
19.
Stark B, Jeison M, Glaser-Gabay L, Bar-Am I, Mardoukh J, Ash S, et al.
Cancer Lett . 2003 Jul; 197(1-2):75-9. PMID: 12880963
Conventional cytogenetic, molecular cytogenic and genetic methods disclosed a broad spectrum of genetic abnormalities leading to gain and loss of chromosomal segments in advanced stage neuroblastoma (NBL). Specific correlation between...
20.
Stark B, Jeison M, Preudhomme C, Fenaux P, Ash S, Korek Y, et al.
Br J Haematol . 2002 Aug; 118(4):1082-6. PMID: 12199789
An intrauterine origin of childhood acute lymphoblastic leukaemia (ALL) was proven by the identical clonotypic gene rearrangement in the concordant leukaemias of monozygotic twins, arising from a single clonogenic progeny....